ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct   Growth logo

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Aggregate Rating: 4/5
Equity Sectoral
Back to Screener

Overview

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

ICICI Prudential Mutual Fund

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Investments in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth are subject to market risks. Please read the offer document carefully before investing to understand the potential market risks and rewards.

Latest NAV

₹ 39.72

Fund Size (AUM)

₹4914.64 Cr

Risk

Very High (Risk rating: 6/10)

Minimum Investment

Lumpsum: ₹ 5000

SIP: ₹100

Launch Date

13-Jul-2018

Expense Ratio

1.18%

Exit Load

Exit load of 1% if redeemed within 15 days.

Benchmark

BSE Healthcare Total Return Index

Standard Deviation

16.26

History

Performance & Ratios

1-Year SIP Return

-0.59%

3-Year SIP Return

27.16%

5-Year SIP Return

22.9%

Mean Return

-0.96%

Alpha

3.62

Beta

0.93

Sharpe Ratio

1.01

Sortino Ratio

1.61

Information Ratio

0.83

Returns
1Y 3Y 5Y All Time
Fund Returns 23.59% 23.82% 26.57% 25.41%
Category Average 19.46% 17.92% 21.75% N/A
Rank Within Category 5 2 1 N/A

Holdings (42)

Company Sector Instrument Assets
Sun Pharmaceutical Industries Ltd. Healthcare Equity 13.5%
Dr. Reddy's Laboratories Ltd. Healthcare Equity 8.95%
Cipla Ltd. Healthcare Equity 8.85%
Divi's Laboratories Ltd. Healthcare Equity 6.71%
Aurobindo Pharma Ltd. Healthcare Equity 5.3%
Lupin Ltd. Healthcare Equity 4.73%
Alkem Laboratories Ltd. Healthcare Equity 4.42%
Mankind Pharma Ltd. Healthcare Equity 3.5%
Gland Pharma Ltd. Healthcare Equity 3.39%
Zydus Lifesciences Ltd. Healthcare Equity 3.1%

Holdings Analysis

Peer Comparison

SIP, STP & SWP Details

Systematic Investment Plan (SIP):

Frequency: Monthly

Min Amount: ₹ 100

Multiplier: 1

Systematic Transfer Plan (STP):

Frequency: MONTHLY

Dates: Any day of the month

Min Amount: ₹ 1000

Min Installments: 6

Systematic Withdrawal Plan (SWP):

Frequency: MONTHLY

Dates: Any day of the month

Min Amount: ₹ 1

Min Installments: 2

AMC Details

Asset Management Company

ICICI Prudential Mutual Fund

ICICI Prudential Mutual Fund started their mutual fund on 13/10/1993 and its managing total assets of ₹2,79,369 Cr. Its ranked at 1 as per total assets at end of 30th Sep 2017. ICICI Prudential Mutual Fund employs robust strategies to manage market risks, but investments remain subject to market risks. Please read the fund’s documentation for detailed risk management policies.

ICICI Prudential is one of the most popular mutual fund investment companies in India.

It is the second largest asset management company (AMC) in the country (as per average assets under management as on 31 December 2018 of Rs. 316,029 Crores

ICICI Prudential AMC's plans to bridge the gap between savings & investments to help create long term wealth & value for investors through innovation, consistency & sustained risk adjusted performance. Invest in ICICI Prudential mutual fund schemes at your convenience and fulfill your long term & short term financial goals. Choose from an array of schemes according to your financial needs and investment objectives. Invest today a lump sum amount or start a systematic investment plan (SIP).

Launch Date

1993-10-12T00:00:00.391Z

Total AUM

₹ 879337.25 Cr

Address

One BKC , A Wing ,13th Floor, Bandra Kurla Complex, Mumbai 400051

Phone

None

Sub Type

Contra

Sub Type Info

Contra funds follow Contrarian strategy which means investing in stocks in contrast to the prevailing sentiment. Minimum investment in equity is 65%.

Tax Impact

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.

Stamp Duty

0.005% (from July 1st, 2020)

Fund Manager Details

Compare with Another Fund

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

ICICI Prudential Mutual Fund

Frequently Asked Questions

How is the overall rating calculated?

The overall rating for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an aggregate score based on performance metrics (returns over 1, 3, and 5 years), risk-adjusted returns (Sharpe and Sortino ratios), and consistency relative to its category. Ratings are on a scale of 1 to 5, with 5 being the highest.

What are the top stocks of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The top stocks held by ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth include Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd..

Which industries does ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth invest in?

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth primarily invests in the following industries: Healthcare, Chemicals, Insurance.

Who are the fund managers of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The fund managers of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth are Dharmesh Kakkad and Sharmila D'mello.

How many years has the fund manager been managing ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

Dharmesh Kakkad: Calculating...
Sharmila D'mello: Calculating...

What is the minimum investment for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The minimum investment for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is ₹5000 for lumpsum investments and ₹100 for SIPs.

What are the average 1-year returns for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

Calculating...

What are the average 3-year returns for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

Calculating...

What is the expense ratio of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth, and how does it compare to its category?

The expense ratio of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is 1.18%. No category comparison data is available.